Blocknomi
Key Highlights On July 24, the FDA granted approval for Lytenava (bevacizumab-vikg) to treat wet AMD, arriving two days before the scheduled July 29 decision date. This marks the first…
Related articles
-
Michael Saylor Escalates Opposition to BIP 110 in Bitcoin Neutrality Debate
Blocknomi Published 19.07.2026 01:10
-
20+ Best Bitcoin & Crypto Casinos & Gambling Sites Switzerland: Top Picks Reviewed & Ranked
Blocknomi Published 22.07.2026 08:02
-
U.S. Government Moves 54,897,092,652 Shiba Inu Seized From FTX
The Crypto Basic Published 16.07.2026 09:40
-
Bitcoin ETFs Edge Closer in Japan as Regulators Tighten Crypto Oversight
CryptoPotato Published 24.07.2026 04:00
-
Oklo (OKLO) Stock Rises as Company Joins $200M Federal Nuclear Program for AI Infrastructure
Blocknomi Published 22.07.2026 17:11
-
Nasdaq-listed Zhibao Technology to Take 3,500 Bitcoin in Proposed PIPE Financing
Bitcoin Magazine Published 22.07.2026 21:15
-
Ethics Provisions in Crypto Clarity Act Caught in Limbo as Senator Lummis Signals More Debate
BlockchainReporter Published 23.07.2026 12:05
-
Moonshot AI Plans Hong Kong IPO After Kimi K3 Model Debut
BeInCrypto Published 19.07.2026 12:30